In the dynamic milieu of hepatocellular carcinoma (HCC), the tumor microenvironment (TME) orchestrates intricate interactions with the adaptive immune system, prominently involving CD8+ cytotoxic T cells and CD4+ helper T cells among tumor-infiltrating lymphocytes (TILs). The gene discussed is CD8A; the disease is neoplasm.